Carol Gleason - Concepedia

Author

Carol Gleason

Bristol-Myers Squibb (United States)

Also Known As

C R Gleason, C.R. Gleason, Carol Gleason, Carol R Gleason, Carol R. Gleason

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Pfizer (United States)United States Food and Drug Administration Covance (United States)

About

Carol Gleason is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and clinical chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	716
2	Health Sciences	7	7	310
3	Engineering	4	4	69
4	Public Health	2	2	33
5	Social Sciences	1	1	19

Carol Gleason

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects Rashmi H. Barbhaiya, S. Thomas Forgue, Carol Gleason, Antimicrobial Agents and Chemotherapy Healthy SubjectsMultiple Intravenous AdministrationsCefepime Linear PharmacokineticsCerebrospinal FluidBioanalysis	1992	125
2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62) Steven P. Piccoli, Devangi Mehta, Alessandra Vitaliti, Bioanalysis	2019	92
Development and Validation of a Preclinical Food Effect Model Kimberley A. Lentz, Megan Quitko, Daniel G. Morgan, Journal of Pharmaceutical Sciences Food ChoiceNutritionFood CompositionFood InnovationAgricultural Economics	2006	84
Correlation between renal membrane binding and nephrotoxicity of aminoglycosides Patricia D. Williams, Damien Bennett, Carol Gleason, Antimicrobial Agents and Chemotherapy Rat Renal CortexRenal FunctionMedicinePhysiologyRenal Membranes	1987	82
Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses Rashmi H. Barbhaiya, S. Thomas Forgue, Carol Gleason, Antimicrobial Agents and Chemotherapy Therapeutic Drug MonitoringUrologyPharmacokinetic EvaluationAntibioticsMedicine	1990	72
International <i>Pig‐a</i> gene mutation assay trial: Evaluation of transferability across 14 laboratories Stephen D. Dertinger, Souk Phonethepswath, Pamela Weller, Environmental and Molecular Mutagenesis	2011	67
Novel probabilistic method for precisely correcting the QT interval for heart rate in telemetered dogs and cynomolgus monkeys Henry H. Holzgrefe, Icilio Cavero, Carol Gleason, Journal of Pharmacological and Toxicological Methods Heart RateElectrophysiological EvaluationNovel Probabilistic MethodBiosignal ProcessingPhysiology	2006	64
Anti-drug Antibody Validation Testing and Reporting Harmonization Heather Myler, João Pedras-Vasconcelos, Kelli R. Phillips, The AAPS Journal Translational MedicineAllergyPreclinical Drug EvaluationReporting HarmonizationImmunology	2021	64
Evaluation of immunogenicity of the T cell costimulation modulator abatacept in patients treated for rheumatoid arthritis. Helen G. Haggerty, Mark A. Abbott, Timothy P. Reilly, PubMed	2007	59
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration Rashmi H. Barbhaiya, Umesh Shukla, Carol Gleason, Antimicrobial Agents and Chemotherapy Tissue PenetrationElimination Half-lifeBioanalysisSkin Blister FluidMedicine	1990	55

Page 1